𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunoadsorption patients with multiple sclerosis: an open-label pilot study

✍ Scribed by A. Moldenhauer; J. Haas; C. Wäscher; T. Derfuss; K.-T. Hoffmann; H. Kiesewetter; A. Salama


Book ID
108711241
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
217 KB
Volume
35
Category
Article
ISSN
0014-2972

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Oral fumaric acid esters for the treatme
✍ S. Schimrigk; N. Brune; K. Hellwig; C. Lukas; B. Bellenberg; M. Rieks; V. Hoffma 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB

An exploratory, prospective, open‐label study of fumaric acid esters (FAE, Fumaderm®) was conducted in patients with relapsing–remitting multiple sclerosis (RRMS). The study consisted of the following four phases: 6‐week baseline, 18‐week treatment (target dose of 720 mg/day), 4‐week washout, and a